This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Shire Human Genetic Therapies, Inc., Takeda Pharmaceutical Company Limited. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016-2024
Title: Innovations by Inventor Yuan Jiang
Introduction
Yuan Jiang is a notable inventor based in Londonderry, NH (US). He has made significant contributions to the field of medical science, particularly in the treatment of lysosomal storage diseases. With a total of 3 patents, his work focuses on advancing therapeutic methods for central nervous system (CNS) delivery.
Latest Patents
Yuan Jiang's latest patents include innovative methods and compositions for CNS delivery of heparan N-sulfatase. The present invention provides, among other things, compositions and methods for CNS delivery of lysosomal enzymes for effective treatment of lysosomal storage diseases. In some embodiments, the present invention includes a stable formulation for direct CNS intrathecal administration comprising a heparan N-sulfatase (HNS) protein, salt, and a polysorbate surfactant for the treatment of Sanfilippo Syndrome Type A.
Career Highlights
Throughout his career, Yuan Jiang has worked with prominent companies in the pharmaceutical industry. He has been associated with Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. His work in these organizations has contributed to the development of innovative therapies aimed at improving patient outcomes.
Collaborations
Yuan Jiang has collaborated with several professionals in his field, including Farah Natoli and Gaozhong Zhu. These collaborations have enhanced his research and development efforts, leading to significant advancements in his area of expertise.
Conclusion
Yuan Jiang's contributions to the field of medical science through his patents and collaborations highlight his commitment to innovation. His work continues to pave the way for new treatments in the realm of lysosomal storage diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile